News
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...
A GLP-1 in pill form from Eli Lilly shows promising results for weight loss and Type 2 diabetes treatment in a trial. FDA ...
GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain ...
According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs ...
GLP-1 inhibitors can manage blood sugar levels in diabetes patients and aid weight loss - and one expert claims there are ...
GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...
GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...
Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results